Combined calcium channel blocker and angiotensin-converting enzyme inhibitor overdose
European Journal of Case Reports in Internal Medicine · 16.10.2026 · 13 (11)
DOI: 10.12890/2026_007381 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 16.10.2026. Verfasst von Fares Kahal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Syrian Private University, Damascus, Syria. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Combined overdoses of angiotensin-converting enzyme inhibitors and calcium channel blockers are rare but associated with more severe toxicity than either agent alone. Case description: A 48-year-old woman presented to the emergency department nine hours after intentionally ingesting 40 tablets of amlodipine (10 mg) and 40 tablets of ramipril (10 mg). On arrival, she was hypotensive and tachycardic. Initial management included fluids, intravenous calcium and insulin bolus followed by high-dose insulin euglycaemic therapy (HIET). Despite escalating vasopressor support, she developed mixed vasoplegic and cardiogenic shock complicated by acute kidney injury, fluid overload, respiratory failure and metabolic acidosis, necessitating intubation and continuous renal replacement therapy. Improvement in haemodynamics was only achieved by day 9. She was transferred from the intensive care unit (ICU) on day 20 with residual weakness from ICU-acquired myopathy and was ultimately discharged after 66 days, with a prolonged hospitalisation attributed to delirium and deconditioning.
Discussion
Severe combined angiotensin-converting enzyme inhibitors (ACEI) and calcium channel blockers (CCB) overdose may cause prolonged, refractory haemodynamic instability requiring extended high-dose insulin euglycaemic therapy (HIET), vasoactive support and fluid administration. Concentrated insulin, dextrose and vasopressor preparations may help mitigate fluid overload. Angiotensin II may be a potential treatment for refractory vasoplegia, although evidence and availability remain limited. Secondary complications can prolong recovery beyond the duration of drug toxicity.
Conclusion
This case highlights the need for individualised, multidisciplinary management, early HIET, vasoactive support and fluid-sparing strategies in severe combined ACEI and CCB overdose.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Syrian Private University, Damascus, Syria.
- Department of Emergency Medicine, McGill University, Montreal, Canada.
- Department of Emergency Medicine, Jewish General Hospital, Montreal, Canada.
- Department of Pharmacy, McGill University Health Center, Montreal, Canada.
- Faculty of Medicine, McGill University, Montreal, Canada.
- Department of Medicine, McGill University Health Centre, Montreal, Canada.
Zitieren
APA
Kahal, F., Guérard-Poirier, N., Ji, C., Gursahaney, A., Perreault, M., & Moussa, G. (2026). Combined calcium channel blocker and angiotensin-converting enzyme inhibitor overdose. European Journal of Case Reports in Internal Medicine, 13(11). https://doi.org/10.12890/2026_007381
Vancouver
Kahal F, Guérard-Poirier N, Ji C, Gursahaney A, Perreault M, Moussa G. Combined calcium channel blocker and angiotensin-converting enzyme inhibitor overdose. European Journal of Case Reports in Internal Medicine. 2026;13(11). doi:10.12890/2026_007381
BibTeX
@article{Kahal2026,
author = {Kahal, Fares and Guérard-Poirier, Natasha and Ji, Cheng and Gursahaney, Ashvini and Perreault, Marc and Moussa, Ghina},
title = {Combined calcium channel blocker and angiotensin-converting enzyme inhibitor overdose},
journal = {European Journal of Case Reports in Internal Medicine},
year = {2026},
volume = {13},
number = {11},
doi = {10.12890/2026_007381}
}
EUVIMED